Table 4:
Comparison of frail versus non-frail patients
| Variable | NON-FRAIL n=911 |
FRAIL n=71 |
P | ||
|---|---|---|---|---|---|
| Median age, years (range) | 71 | 65-96 | 75 | 66-92 | <0.001 |
| Race | |||||
| American Indian/Alaska Native | 1 | 0.1 | 0 | 0.0 | 0.298 |
| White | 771 | 84.6 | 60 | 84.5 | |
| Asian | 28 | 3.1 | 0 | 0.0 | |
| Black | 48 | 5.3 | 7 | 9.9 | |
| Unknown | 63 | 6.9 | 4 | 5.6 | |
| Median BMI, kg/m2 (range) | 28.7 | 14.2-65.1 | 35.1 | 20-56.6 | <0.001 |
| ECOG performance status | |||||
| 0 | 720 | 79.1 | 6 | 8.5 | <0.001 |
| 1 | 176 | 19.3 | 30 | 42.3 | |
| 2 | 13 | 1.4 | 28 | 39.4 | |
| 3 | 1 | 0.1 | 6 | 8.5 | |
| 4 | 0 | 0.0 | 1 | 1.4 | |
| 5 | 0 | 0.0 | 0 | 0.0 | |
| Previous abdominal surgery | 472 | 51.8 | 35 | 49.3 | 0.683 |
| Indication for surgery | |||||
| Benign | 62 | 6.8 | 2 | 2.8 | 0.047 |
| Uterine hyperplasia | 41 | 4.5 | 0 | 0.0 | |
| Uterine cancer | 554 | 60.8 | 53 | 74.6 | |
| Breast cancer/risk-reducing | 9 | 1.0 | 0 | 0.0 | |
| Benign adnexal mass | 143 | 15.7 | 4 | 5.6 | |
| Ovarian/fallopian tube cancer | 66 | 7.2 | 8 | 11.3 | |
| Cervical dysplasia | 5 | 0.5 | 1 | 1.4 | |
| Cervical cancer | 21 | 2.3 | 1 | 1.4 | |
| Two gynecologic primaries | 4 | 0.4 | 0 | 0.0 | |
| Lymphoma | 3 | 0.3 | 1 | 1.4 | |
| Other | 3 | 0.3 | 1 | 1.4 | |
| Procedure | |||||
| Minor | 124 | 13.6 | 7 | 9.9 | 0.370 |
| Major | 787 | 86.4 | 64 | 90.1 | |
| Median estimated blood loss, cc (range) | 50 | 0-800 | 50 | 10-300 | 0.070 |
| Median uterine size, g (range) # | n=777 90 |
27-740 | n=62 115 |
39-429 | 0.015 |
| Median operating room time, min (range) | 154 | 40-476 | 149 | 61-417 | 0.700 |
| Median length of hospital stay, days (range) | 0 | 0-19 | 1 | 0-11 | <0.001 |
| Intraoperative complication | 4 | 0.4 | 0 | 0 | 0.576 |
| Postoperative complication | 67 | 7.4 | 10 | 14.1 | 0.042 |
| Major complication (grade 3-5) | 18 | 2.0 | 5 | 7 | 0.007 |
| Readmission within 30 days | 30 | 3.3 | 4 | 5.6 | 0.299 |
| Death within 90 days | 3 | 0.3 | 2 | 2.8 | 0.05 |
ECOG, Eastern Cooperative Oncology Group
#
only 839 patients were evaluated for uterine size